155 related articles for article (PubMed ID: 12903008)
1. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment.
Williams J; Chen Y; Rubin P; Finkelstein J; Okunieff P
Semin Radiat Oncol; 2003 Jul; 13(3):182-8. PubMed ID: 12903008
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue effects: reporting and analysis.
Bentzen SM; Dörr W; Anscher MS; Denham JW; Hauer-Jensen M; Marks LB; Williams J
Semin Radiat Oncol; 2003 Jul; 13(3):189-202. PubMed ID: 12903009
[TBL] [Abstract][Full Text] [Related]
3. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.
Trotti A; Colevas AD; Setser A; Rusch V; Jaques D; Budach V; Langer C; Murphy B; Cumberlin R; Coleman CN; Rubin P
Semin Radiat Oncol; 2003 Jul; 13(3):176-81. PubMed ID: 12903007
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
[TBL] [Abstract][Full Text] [Related]
7. The grading of lymphedema in oncology clinical trials.
Cheville AL; McGarvey CL; Petrek JA; Russo SA; Thiadens SR; Taylor ME
Semin Radiat Oncol; 2003 Jul; 13(3):214-25. PubMed ID: 12903011
[TBL] [Abstract][Full Text] [Related]
8. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
[TBL] [Abstract][Full Text] [Related]
9. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
11. [Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment].
Shimizu T; Saijo N
Nihon Rinsho; 2003 Jun; 61(6):937-42. PubMed ID: 12806939
[TBL] [Abstract][Full Text] [Related]
12. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. Regimen-related gastrointestinal toxicities in cancer patients.
Sonis ST
Curr Opin Support Palliat Care; 2010 Mar; 4(1):26-30. PubMed ID: 20040879
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of early and late toxicities in chemoradiation trials.
Bentzen SM; Trotti A
J Clin Oncol; 2007 Sep; 25(26):4096-103. PubMed ID: 17827459
[TBL] [Abstract][Full Text] [Related]
16. Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives.
Seegenschmiedt MH
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():25-9. PubMed ID: 9830452
[TBL] [Abstract][Full Text] [Related]
17. Late radiation-related fibrosis: pathogenesis, manifestations, and current management.
O'Sullivan B; Levin W
Semin Radiat Oncol; 2003 Jul; 13(3):274-89. PubMed ID: 12903016
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
19. Long-term health status among survivors of childhood cancer: does sex matter?
Armstrong GT; Sklar CA; Hudson MM; Robison LL
J Clin Oncol; 2007 Oct; 25(28):4477-89. PubMed ID: 17906209
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic pain in cancer survivors.
Levy MH; Chwistek M; Mehta RS
Cancer J; 2008; 14(6):401-9. PubMed ID: 19060605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
